Sign in

You're signed outSign in or to get full access.

Jason O’Neill

Chief Operating Officer at New Horizon Aircraft
Executive
Board

About Jason O’Neill

Jason O’Neill (age 48) is Chief Operating Officer of New Horizon Aircraft Ltd. (HOVR) and served as a Class II director until 2025; he previously served as COO of Legacy Horizon since January 2019. He attended the University of Toronto and University of Waterloo, and has 20+ years in senior roles scaling tech-based startups . HOVR remains pre-revenue and in R&D/build phases toward a Cavorite X7 eVTOL certification; no TSR, revenue or EBITDA growth metrics are disclosed, with first commercial deliveries targeted prior to 2030 .

Past Roles

OrganizationRoleYearsStrategic Impact
CenttricDirector of Product & Strategy13 years Built product strategy for tech-focused ventures; scaled startup operations
ThoughtwireDirector of Product & Data~10 years Led data/product; senior roles in problem-solution leveraging leading-edge technologies

External Roles

OrganizationRoleYearsStrategic Impact
Not disclosed

Fixed Compensation

Metric (CAD unless noted)FY 2024FY 2025
Base Salary$212,029 $254,125
Bonus$38,250 (settled in Class A shares)
Stock Awards$74,273
Option Awards$156,880
Total$212,029 $523,528

Employment agreement terms (currency per agreement):

  • Base salary: CAD $240,000 for COO (updated vs CAD $225,000 in 2024 agreement) .
  • At-will employment under Ontario ESA; termination without cause provides statutory entitlements plus “Additional Pay in Lieu of Notice” to ensure a minimum of 12 months, increasing by 1 month per completed year to a max of 24 months, plus prorated bonus based on average of prior two years during the severance period .

Performance Compensation

Awards and mechanics (metrics/weights not disclosed):

  • Short-Term Incentive (STIP): FY2025 bonus $38,250, paid in stock .
  • PSUs: Plan authorizes PSUs; performance criteria set at grant; vesting upon meeting conditions, with redemption into shares; detailed metric targets/weights not disclosed .
  • Options: 10-year options; vest in 3 equal annual tranches; exercise price set at or above fair market value; acceleration permitted on takeover/change-of-control .
Award TypeGrant/StatusKey TermsVesting/Expiry
STIP Bonus$38,250 FY2025Paid in Class A shares N/A
RSUs (Unvested)74,000 units (MV $107,918)RSUs settle in cash or shares at Board’s discretion; vesting period set at grant Vesting schedule not disclosed
Options (Aug 2, 2030)97,502 exercisable; 48,750 unexercisable @ $0.553-year equal-tranche vesting; originally CAD $0.76 strike converted to USD for table Expire Aug 2, 2030
Options (Feb 2, 2035)296,000 unexercisable @ $0.613-year equal-tranche vesting Expire Feb 2, 2035

Equity Ownership & Alignment

MetricAs of Nov 12, 2024As of Oct 21, 2025
Shares Beneficially Owned402,731 890,577
Percent of Class1.6% 2.1%
Options (legacy strike CAD$0.76 / ~USD$0.55)146,252 included; fully vested basis in table 97,502 exercisable; 48,750 unexercisable @ $0.55 (exp. 2030)
Options (USD $0.61)296,000 unexercisable @ $0.61 (exp. 2035)
Unvested RSUs74,000 (MV $107,918)

Alignment/controls:

  • Insider policy prohibits pledging, margin purchases, or derivative transactions (puts/calls) in Company stock .
  • Policy permits 10b5-1 trading plans for executives/directors .
  • Non-compete and non-solicit agreements (2 years post-Closing, signed Jan 12, 2024) .
  • Clawback provisions embedded in Omnibus Share Incentive Plan (Article 9.3) .

Section 16 compliance:

  • One Form 3 filing for Mr. O’Neill reported late in FY2025 .

Employment Terms

TermDetails
Start/RoleCOO since Jan 2019 (Legacy Horizon); COO & director since Business Combination; director service ended with 2025 not being re-nominated
At-Will/TerminationOntario ESA-based; without cause: statutory plus Additional Pay in Lieu to minimum 12 months, increasing by 1 month per completed year to 24 months max; prorated bonus based on average of prior two years during severance period
Change-of-ControlDouble-trigger: Good Reason within 2 years post-CoC entitles same severance benefits as without cause; Good Reason includes material title/duties change, salary reduction, benefits reduction, or material diminution
Equity AccelerationOptions may accelerate on takeover/change-of-control per plan
Non-Compete/Non-SolicitTwo-year non-compete and non-solicit agreements from Jan 12, 2024
Base SalaryCAD $240,000 in FY2025 agreement; CAD $225,000 in FY2024 agreement
BenefitsParticipation in pension/health plans; ESPP with company match (50%) and holding period for matched shares

Board Governance

  • Service: Class II director (2024–2025); not nominated for re-election in 2025 and continued as COO .
  • Independence: Not independent due to executive role; he is the brother-in-law of CEO Brandon Robinson (related-party flag) .
  • Committees: None; audit, compensation, and nominating committees comprised solely of independent directors .
  • Attendance: Board held four meetings in FY2025; each member attended ≥75% of Board and committee meetings during their service .
  • Director Pay: Employee directors do not receive additional pay for Board service .

Investment Implications

  • Pay-for-performance visibility is limited: no disclosed performance metric weights/targets, and pre-revenue status constrains benchmarking; however, equity-heavy mix (options, RSUs, ESPP) aligns upside with long-term value creation .
  • Retention/overhang: Significant unvested options (through 2035) and RSUs suggest ongoing service incentives but may create selling pressure as tranches vest; 10b5-1 plans can smooth execution while anti-pledging reduces alignment risk .
  • Governance risks: Dual-role and family relationship with the CEO raise independence concerns; Mr. O’Neill’s removal from the slate in 2025 reduces dual-role risk while preserving operational continuity as COO (net positive for governance optics) .
  • Change-of-control economics: Double-trigger severance (up to 24 months base salary plus prorated bonus) and potential option acceleration could be material in an M&A scenario; model for transaction costs accordingly .
  • Execution risk: Company-level risks remain high—no commercial revenue, long certification timeline, and material dependence on future capital; management disclosed R&D scale-up and going-concern considerations reliant on financing .